Latigo Biotherapeutics
All
Newsflash
Article
-
Latigo Biotherapeutics (LTGO) completes IPO, raising nearly $350 million, with its non-opioid pain drug LTG-001 showing 50% greater relief than hydrocodone in trials.
The clinical-stage biopharmaceutical company priced its IPO at $18 per share and opened at $21. Latigo focuses on non-opioid pain medicines, and its lead asset LTG-001 for acute pain demonstrated 50%
-
Latigo Biotherapeutics (LTGO) completes IPO, raising nearly $350 million, with its non-opioid pain drug LTG-001 showing 50% greater relief than hydrocodone in trials.
The clinical-stage biopharmaceutical company priced its IPO at $18 per share and opened at $21. Latigo focuses on non-opioid pain medicines, and its lead asset LTG-001 for acute pain demonstrated 50%
- No data
Latigo Biotherapeutics
Svmuu provides news and information related to Latigo Biotherapeutics, as well as real-time data on Latigo Biotherapeutics. We provide in-depth analysis and interpretation of the latest Latigo Biotherapeutics developments, helping investors stay informed about Latigo Biotherapeutics policy updates. Svmuu is your essential tool for keeping up with the latest Latigo Biotherapeutics trends! Here, we’ll join you in keeping a close eye on Latigo Biotherapeutics news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Yangtze Optical Fibre and Cable (YOFC) plunged 16.03% in Hong Kong trading, while UBS bucked the trend by raising its net profit forecasts for the company by 116%-158% for 2026-28 and maintaining a "buy" rating.
-
2
Renowned investor Duan Yongping has once again purchased 30,000 shares of Kweichow Moutai, spending over 36.9 million yuan.
-
3
NEAR Protocol (NEAR) Outlook: Future Potential Driven by Technological Innovation and Ecosystem Expansion
-
4
XRP's Global Acceptance and Impact: Regulation, Applications, and Market Dynamics
-
5
THC Coin Analysis: Trading Status and Risks of Transhuman Coin and Thetan Coin
-
6
SAITAMA Coin: An Analysis of Its Evolution from Meme to SaitaChain and Current Status
-
7
DEXA Coin: An Analysis of the Current Status of the ERC-20 Token Formerly Positioned for Social Payments
-
8
Zhuhai Amicro Technology, a robot chip designer backed by Xiaomi, has passed its listing hearing and plans to raise over $100 million in an IPO in Hong Kong.
-
9
Cryptocurrency Exchange Selection Guide: Global Compliance and Risk Analysis
-
10
GOETH Token Analysis: Wrapped Ethereum on Algorand and Its Market Dynamics
Markets Today
Recommended Reading







